The effect of sodium nitroprusside on psychotic symptoms and spatial working memory in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial
Sodium nitroprusside (SNP) has been reported to rapidly reduce psychotic symptoms in patients with schizophrenia. This has the potential to revolutionize treatment for schizophrenia. In this study, we tested the hypothesis that SNP leads to a reduction in psychotic symptoms and an improvement in spa...
Glavni autori: | Stone, J, Morrison, P, Gao, F, Koychev, I, Reilly, T, Kolanko, M, Mohammadinasab, A, Kapur, S, McGuire, P |
---|---|
Format: | Journal article |
Jezik: | English |
Izdano: |
Cambridge University Press
2016
|
Slični predmeti
-
Reply to: Letter to the editor: Sodium nitroprusside for schizophrenia: Could methodological variables account for the different results obtained?
od: Stone, J, i dr.
Izdano: (2017) -
Antidepressant controlled trial for negative symptoms in schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial.
od: Barnes, T, i dr.
Izdano: (2016) -
Impact of negative symptoms on functioning and quality of life in first psychotic episodes of schizophrenia
od: García-Fernández, Lorena, i dr.
Izdano: (2023) -
Response of Arabidopsis thaliana seedlings to lead exposure: effect of pre-treatment with sodium nitroprusside
od: Phang, Ing Chia, i dr.
Izdano: (2009) -
Response of Arabidopsis thaliana seedlings to lead exposure: effect of pre-treatment with sodium nitroprusside
od: Phang, Ing Chia, i dr.
Izdano: (2009)